The board of Directors of the Aurbindo Pharma at its meeting held today, May 31,2021, has inter alia, based on
the recommendation of the Nomination and Remuneration Committee and subject to the approval of the
members in the forthcoming Annual General Meeting, has approved:
- The re-appointment of Mr. N. Govindarajan as Managing Director of the Aurbindo Pharma for a period of 3 years with effect from June 1,2021.
Mr. N. Govindarajan, is a B.E (Mechanical) from Annamalai University. He has close to 3 decades of experience across a variety of domains in pharmaceutical industry such as active ingredients, CRAMS, Finished Dosages, Biotechnology and vaccines. He joined Aurobindo Pharma Limited as Chief Executive Officer (API and CRAMS) in late 2010. Mr. N. Govindarajan oversees the Active Pharmaceutical Ingredients (APls) Operations and CRAMS business of the Company. Prior to joining Aurobindo Pharma, Mr. N. Govindarajan served as the Managing Director and CEO of Shasun Pharmaceuticals Limited.